Vol 14: An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study.Report as inadecuate



 Vol 14: An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study.


Vol 14: An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 14: An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study.
This article is from Cancer Cell International, volume 14.AbstractBackground: 2-Methoxyestradiol is known to have antitumour and antiproliferative action in vitro and in vivo.
However, when 2-methoxyestradiol is orally administered, it is rapidly oxidized by the enzyme 17β-hydroxysteriod dehydrogenase in the gastrointestinal tract.
Therefore, 2-

Author: Repsold, Lisa; Pretorius, Etheresia; Joubert, Annie Margaretha

Source: https://archive.org/





Related documents